Wayne Blevins
Emergency Medicine · Carlinville, ILNPI 1902803869
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 306 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Among emergency medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 306 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$909
- Amgen$656
- AstraZeneca$615
- AbbVie$545
- Novartis$430
- Lilly USA, LLC$269
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,163100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 59 | $909 |
| Amgen | 32 | $656 |
| AstraZeneca | 35 | $615 |
| AbbVie | 34 | $545 |
| Novartis | 40 | $430 |
| Lilly USA, LLC | 14 | $269 |
| Pfizer | 10 | $190 |
| Otsuka America Pharmaceutical, Inc. | 7 | $163 |
| Braeburn Inc. | 7 | $156 |
| Astellas Pharma US Inc | 7 | $135 |
| Boehringer Ingelheim | 7 | $123 |
| E.r. Squibb & Sons, L.L.C. | 6 | $97 |
| Mylan Specialty L.p. | 6 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $88 |
| Johnson & Johnson | 3 | $82 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $71 |
| Amarin Pharma, Inc. | 3 | $58 |
| Biogen | 3 | $51 |
| Viatris Specialty LLC | 3 | $50 |
| Verity Pharmaceuticals Inc. | 2 | $48 |
| Seqirus USA Inc | 1 | $42 |
| Lundbeck LLC | 3 | $41 |
| Neurocrine Biosciences, Inc. | 2 | $31 |
| Medtronic | 2 | $28 |
| Philips North America LLC | 2 | $28 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Bayer | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Abbott | 1 | $17 |
| Indivior Inc. | 1 | $15 |
| Qiagen, LLC | 1 | $13 |
| Gilead | 1 | $13 |
How this compares
$5,163 in reported general payments places this provider in the 95th percentile of 2,434 emergency medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 71 | $72,176 |
| EliquisApixaban | 45 | $42,030 |
| JardianceEmpagliflozin | 25 | $21,946 |
| RexultiBrexpiprazole | 12 | $16,788 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $14,690 |
| XareltoRivaroxaban | 18 | $5,105 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $3,584 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $2,169 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 118 | $1,722 |
| Gabapentin | 69 | $1,610 |
| Atorvastatin Calcium | 112 | $1,355 |
| Paliperidone ErPaliperidone | 13 | $1,132 |
| Ventolin HfaAlbuterol Sulfate | 20 | $1,129 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 45 | $1,087 |
| Memantine Hcl | 19 | $1,001 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $909 | $72,17671 claims |
| PfizerEliquis | $190 | $42,03045 claims |
| Boehringer IngelheimJardiance | $123 | $21,94625 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $163 | $16,78812 claims |
| Johnson & JohnsonXarelto | $82 | $5,10518 claims |
| AstraZenecaSymbicort | $615 | $3,58415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,434 emergency medicine providers in Illinois.
Other emergency medicine in Carlinville
- Kristen FergusonSpringfield$511K
- Christopher RossChicago$132K
- Erik KulstadChicago$109K
- Philip MitchellNormal$107K
- Adam GoodcoffChicago$98K
- Walter BradleyRock Island$90K
- Pratik MehtaChicago$74K
- Janet LinChicago$66K
- Yanina Purim Shem TovChicago$60K
- Robert TurelliChicago$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.